Becker muscular dystrophy

Last revised by Rohit Sharma on 20 Aug 2023

Becker muscular dystrophy (BMD) is a dystrophinopathy that is considered to be a milder form of Duchenne muscular dystrophy.

It may be present in 3 to 6 per 100,000 male births. The condition is extremely rare in females due to its inheritance pattern, as discussed below.

The onset of weakness, usually affecting the pelvis and lower limbs, is usually seen after age 7 years and often in the second decade. Unlike Duchenne muscular dystrophy, the weakness is often less disabling and non-musculoskeletal features, such as intellectual disability or cardiomyopathy, are often less prominent and severe.

It is caused by mutations that allow expression of reduced amounts of, or a partially functional, dystrophin protein. 

It follows an X-linked recessive inheritance secondary to mutations in the DMD gene.

Prominent involvement of the gluteus maximus and medius, adductor magnus, adductor longusbiceps femoris long head, vasti, semitendinosus, and semimembranosus may be present 1,2

Prominent involvement of the teres major, triceps brachii long head, and biceps brachii long head may be present 1,2

Similar to Duchenne muscular dystrophy, corticosteroids have an important role in management 4. Otherwise, management of Becker muscular dystrophy is multidisciplinary, and involves rehabilitation and surveillance of respiratory, cardiac, and orthopedic complications. All of these complications are less frequent and severe in nature compared to Duchenne muscular dystrophy, and thus, the quality of life and prognosis tends to be better.

It is named after Peter Emil Becker (1908-2000), a German neurologist and geneticist, who first described the condition in 1955 3.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.